113 related articles for article (PubMed ID: 36087784)
1. Development of exploratory algorithms to aid in risk of malignancy prediction of indeterminate pulmonary nodules.
Jeanblanc N; Jackson L; Gawel S; Brophy S; Vaidya S; Syed S; Davis GJ; Borgia JA
Clin Chim Acta; 2022 Oct; 535():197-202. PubMed ID: 36087784
[TBL] [Abstract][Full Text] [Related]
2. Improving malignancy risk prediction of indeterminate pulmonary nodules with imaging features and biomarkers.
Marmor HN; Jackson L; Gawel S; Kammer M; Massion PP; Grogan EL; Davis GJ; Deppen SA
Clin Chim Acta; 2022 Sep; 534():106-114. PubMed ID: 35870539
[TBL] [Abstract][Full Text] [Related]
3. Combining serum miRNAs, CEA, and CYFRA21-1 with imaging and clinical features to distinguish benign and malignant pulmonary nodules: a pilot study : Xianfeng Li et al.: Combining biomarker, imaging, and clinical features to distinguish pulmonary nodules.
Li X; Zhang Q; Jin X; Cao L
World J Surg Oncol; 2017 May; 15(1):107. PubMed ID: 28545454
[TBL] [Abstract][Full Text] [Related]
4. How Are Indeterminate Pulmonary Nodules at Diagnosis Associated with Survival in Patients with High-Grade Osteosarcoma?
Tsoi KM; Lowe M; Tsuda Y; Lex JR; Fujiwara T; Almeer G; Gregory J; Stevenson J; Evans SE; Botchu R; Jeys LM
Clin Orthop Relat Res; 2021 Feb; 479(2):298-308. PubMed ID: 32956141
[TBL] [Abstract][Full Text] [Related]
5. Contribution of a Blood-Based Protein Biomarker Panel to the Classification of Indeterminate Pulmonary Nodules.
Ostrin EJ; Bantis LE; Wilson DO; Patel N; Wang R; Kundnani D; Adams-Haduch J; Dennison JB; Fahrmann JF; Chiu HT; Gazdar A; Feng Z; Yuan JM; Hanash SM
J Thorac Oncol; 2021 Feb; 16(2):228-236. PubMed ID: 33137463
[TBL] [Abstract][Full Text] [Related]
6. Differences in VA and Non-VA Pulmonary Nodules: All Evaluations Are not Created Equal.
New ML; Hirsch EA; Feser WJ; Malkoski SP; Garg K; Miller YE; Baron AE
Clin Lung Cancer; 2023 Jul; 24(5):407-414. PubMed ID: 37012147
[TBL] [Abstract][Full Text] [Related]
7. Validation of Histoplasmosis Enzyme Immunoassay to Evaluate Suspicious Lung Nodules.
Shipe ME; Deppen SA; Sullivan S; Kammer M; Starnes SL; Wilson DO; Massion PP; Grogan EL
Ann Thorac Surg; 2021 Feb; 111(2):416-420. PubMed ID: 32682756
[TBL] [Abstract][Full Text] [Related]
8. A clinical-radiomics nomogram for the preoperative prediction of lung metastasis in colorectal cancer patients with indeterminate pulmonary nodules.
Hu T; Wang S; Huang L; Wang J; Shi D; Li Y; Tong T; Peng W
Eur Radiol; 2019 Jan; 29(1):439-449. PubMed ID: 29948074
[TBL] [Abstract][Full Text] [Related]
9. A prediction model based on DNA methylation biomarkers and radiological characteristics for identifying malignant from benign pulmonary nodules.
Xing W; Sun H; Yan C; Zhao C; Wang D; Li M; Ma J
BMC Cancer; 2021 Mar; 21(1):263. PubMed ID: 33691657
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic follow-up of indeterminate pulmonary nodules in the Medicare population.
Pinsky PF; Osarogiagbon R
Cancer; 2023 Sep; 129(18):2808-2816. PubMed ID: 37208803
[TBL] [Abstract][Full Text] [Related]
11. Isotypic analysis of grass-pollen-specific immunoglobulins in human plasma. 2. Quantification of the IgE, IgM, IgA class and the IgG subclass antibodies.
Batard T; Basuyaux B; Laroze A; Lambin P; Brémard-Oury C; Aucouturier P; Hamilton RG; David B; Peltre G
Int Arch Allergy Immunol; 1993; 102(3):279-87. PubMed ID: 8219781
[TBL] [Abstract][Full Text] [Related]
12. Autoantibody Signature Enhances the Positive Predictive Power of Computed Tomography and Nodule-Based Risk Models for Detection of Lung Cancer.
Massion PP; Healey GF; Peek LJ; Fredericks L; Sewell HF; Murray A; Robertson JF
J Thorac Oncol; 2017 Mar; 12(3):578-584. PubMed ID: 27615397
[TBL] [Abstract][Full Text] [Related]
13. Improving lung cancer diagnosis with cancer, fungal, and imaging biomarkers.
Marmor HN; Kammer MN; Deppen SA; Shipe M; Welty VF; Patel K; Godfrey C; Billatos E; Herman JG; Wilson DO; Kussrow AK; Bornhop DJ; Maldonado F; Chen H; Grogan EL
J Thorac Cardiovasc Surg; 2023 Sep; 166(3):669-678.e4. PubMed ID: 36792410
[TBL] [Abstract][Full Text] [Related]
14. Accuracy of a Novel Histoplasmosis Enzyme Immunoassay to Evaluate Suspicious Lung Nodules.
Deppen SA; Massion PP; Blume J; Walker RC; Antic S; Chen H; Durkin MM; Wheat LJ; Grogan EL
Cancer Epidemiol Biomarkers Prev; 2019 Feb; 28(2):321-326. PubMed ID: 30341097
[TBL] [Abstract][Full Text] [Related]
15. Predictive factors for malignancy in incidental pulmonary nodules detected in breast cancer patients at baseline CT.
Hammer MM; Mortani Barbosa EJ
Eur Radiol; 2017 Jul; 27(7):2802-2809. PubMed ID: 27798753
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of models for predicting the probability of malignancy in patients with pulmonary nodules.
Li Y; Hu H; Wu Z; Yan G; Wu T; Liu S; Chen W; Lu Z
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32068231
[TBL] [Abstract][Full Text] [Related]
17. Association of CEA, NSE, CYFRA 21-1, SCC-Ag, and ProGRP with Clinicopathological Characteristics and Chemotherapeutic Outcomes of Lung Cancer.
Bi H; Yin L; Fang W; Song S; Wu S; Shen J
Lab Med; 2023 Jul; 54(4):372-379. PubMed ID: 36282321
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary nodules and metastases in colorectal cancer.
Nordholm-Carstensen A
Dan Med J; 2016 Jan; 63(1):B5190. PubMed ID: 26726908
[TBL] [Abstract][Full Text] [Related]
19. A Gene Expression Classifier from Whole Blood Distinguishes Benign from Malignant Lung Nodules Detected by Low-Dose CT.
Kossenkov AV; Qureshi R; Dawany NB; Wickramasinghe J; Liu Q; Majumdar RS; Chang C; Widura S; Kumar T; Horng WH; Konnisto E; Criner G; Tsay JJ; Pass H; Yendamuri S; Vachani A; Bauer T; Nam B; Rom WN; Showe MK; Showe LC
Cancer Res; 2019 Jan; 79(1):263-273. PubMed ID: 30487137
[TBL] [Abstract][Full Text] [Related]
20. Human Epididymis Protein 4 (HE4) in Patients with Small-Cell Lung Cancer.
Wojcik E; Tarapacz J; Rychlik U; Stasik Z; Sas-Korczynska B; Skotnicki P; Kulpa JK
Clin Lab; 2016 Sep; 62(9):1625-1632. PubMed ID: 28164590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]